home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

76 rows where filing_year = 2026 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, government_entities, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 76 ✖

filing_year 1

  • 2026 · 76 ✖

filing_period 1

  • first_quarter 76
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3801209 AMERICAN ACADEMY OF AUDIOLOGY 50825527-9266-4fca-acaf-cb2906eeb942 Q1 AMERICAN ACADEMY OF AUDIOLOGY 79370 AMERICAN ACADEMY OF AUDIOLOGY 2026 first_quarter MED Prevention of elimination of NIH funding FY'2026 LHHS Appropriations Act Early Hearing Detection Intervention Program HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-03-17T15:17:05-04:00
3801244 AMERICAN ACADEMY OF AUDIOLOGY 58bf05f8-c0ad-4b0f-b7b9-78267e1406ac 1A AMERICAN ACADEMY OF AUDIOLOGY 79370 AMERICAN ACADEMY OF AUDIOLOGY 2026 first_quarter MED Prevention of elimination of NIH funding FY'2026 LHHS Appropriations Act Early Hearing Detection Intervention Program HR 6718, Professional Student Loan Legislation Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-03-24T10:50:16-04:00
3801405 NELSON MULLINS RILEY & SCARBOROUGH 9269e7d3-5465-4208-878f-824c43348f4b Q1 NELSON MULLINS RILEY & SCARBOROUGH 285871 ANBEX, INC. 2026 first_quarter MED Stockpile potassium iodide to counteract effects of nuclear radiation. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2026-03-31T10:20:31-04:00
3801420 MCDERMOTT+ LLC 32838a64-46ca-4776-9bbc-b95aa4889be2 Q1 MCDERMOTT+ LLC 401103287 VERILY LIFE SCIENCES LLC 2026 first_quarter MED Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2026-03-31T11:18:11-04:00
3801497 REPUBLIC CONSULTING, LLC 3e04fbbc-9474-4f35-9400-0f9af96ff694 Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2026 first_quarter MED Monitor health data budgets and policy. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2026-03-31T17:58:40-04:00
3801736 AUBURN HEALTH STRATEGIES, LLC 5ee903be-9d32-4ae7-b26a-8082e7039291 Q1 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2026 first_quarter MED proficiency testing for clinical laboratories Centers For Medicare and Medicaid Services (CMS),Office of Management & Budget (OMB)     0 0 2026-04-01T15:11:16-04:00
3801766 MAGILL ASSOCIATES, LLC 588746ab-f44e-44bd-abc2-a8796efa28f2 Q1 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2026 first_quarter MED FY 2027 appropriations for the development of a synthetic vaccine HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-04-01T16:24:01-04:00
3801784 ESHAM STRATEGIES LLC 9a835b5e-2b2a-4691-9f5c-cf9a3325ecc4 Q1 ESHAM STRATEGIES LLC 401109169 ACCUMULUS SYNERGY, INC. 2026 first_quarter MED Issues related to regulatory information exchange policies.   20000   0 0 2026-04-01T18:54:55-04:00
3801807 CURE SMA db9eadc1-42de-444d-85eb-7d9478453c88 Q1 CURE SMA 401104586 CURE SMA 2026 first_quarter MED medical research in spinal muscular atrophy, development and approval of spinal muscular atrophy treatments, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, U.S. Department of Defense Congressionally Directed Medical Research Program funding, Medical Research for Our Troops Act (H.R. 3906) Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   75000 0 0 2026-04-01T21:02:59-04:00
3802253 DQB INTERNATIONAL bb906345-b5f5-4843-ae26-5456d09de7e4 Q1 DQB INTERNATIONAL 291834 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2026 first_quarter MED FY 2027 Labor, HHS Appropriations Bill HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-04-03T12:38:31-04:00
3802335 RAY C CULVER III 9c7fbae9-442a-40be-bdb6-83e8bc7e24e1 Q1 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2026 first_quarter MED USDA ARS Human Nutrition Research funding in the FY2026 Agriculture Appropriations (P.L. 119-37) and in the developing FY2027 Agricultural Appropriations bill. USDA ARS Human Nutrition Research funding authority in the reauthorization of the Agriculture Improvement Act of 2018, P.L. 115-334. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2026-04-03T23:19:55-04:00
3802620 AMERICAN COLLEGE OF CLINICAL PHARMACY 58510a27-6378-4fdf-a0e3-f68305b77605 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2026 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2026-04-06T11:07:36-04:00
3802762 SQUIRE PATTON BOGGS 2a97fede-b396-4761-a1e4-804347603a63 Q1 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2026 first_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2026-04-06T14:19:01-04:00
3802956 BLUEBIRD STRATEGIES a5b8c0db-2e9e-4fb5-aae5-c7458d84c34c Q1 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2026 first_quarter MED Funding for myotonic dystrophy research as part of the FY27 Congressionally Directed Medical Research Program & Peer Review Medical Research Program. HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-04-06T16:44:57-04:00
3802970 BLUEBIRD STRATEGIES d324f04a-945b-4611-9776-cfe4de36c560 Q1 BLUEBIRD STRATEGIES 401105447 NCATS ALLIANCE 2026 first_quarter MED FY27 NIH/NCATS Appropriations Funding HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2026-04-06T16:49:30-04:00
3803112 SQUIRE PATTON BOGGS 6a556780-41ae-47c9-ade6-b7747fe2e8f8 Q1 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2026 first_quarter MED Funding support for federally qualified health centers; reauthorization of programs   20000   0 0 2026-04-07T08:24:30-04:00
3803236 CORNERSTONE GOVERNMENT AFFAIRS, INC. 28ff982d-f5ce-42b2-88ae-def42f7b799e Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 HAZELDEN BETTY FORD FOUNDATION 2026 first_quarter MED Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-07T12:45:10-04:00
3803376 CORNERSTONE GOVERNMENT AFFAIRS, INC. dcb6eba5-9571-4cab-b784-1c876d6cf25b Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE UNIVERSITY OF TEXAS SYSTEM 2026 first_quarter MED Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2026-04-07T15:25:19-04:00
3803662 GRANITE CAPITOL CONSULTING LLC f5122c13-ed21-40fc-b59a-367df1ae7c01 Q1 GRANITE CAPITOL CONSULTING LLC 401108946 QURALIS 2026 first_quarter MED FDA Related Issues HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-04-08T08:41:33-04:00
3803721 CORNERSTONE GOVERNMENT AFFAIRS, INC. a45c0915-6ca3-408e-a5b1-482af2d87dd3 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MMV MEDICINES FOR MALARIA VENTURE 2026 first_quarter MED The purpose was to increase funding for malaria research in the Department of Defense. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-08T09:53:29-04:00
3803783 CORNERSTONE GOVERNMENT AFFAIRS, INC. ba067a96-5a5e-4fa4-bf2f-15b81b50ee55 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 RADIATRIC, INC. 2026 first_quarter MED Issues related to funding for photonics research. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-08T11:13:45-04:00
3803794 CORNERSTONE GOVERNMENT AFFAIRS, INC. 41828542-8cd8-45dd-83bd-f9451370c382 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE UNIVERSITY OF TEXAS AT SAN ANTONIO 2026 first_quarter MED Identify federal funding opportunities and partnerships with federal agencies. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-08T11:16:12-04:00
3803995 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 9774c6a7-9901-496c-b7eb-3c9e7e3500b2 Q1 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 59650 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 2026 first_quarter MED Lobbied in support in increased funding for biomedical research in the VA, NIH and DoD HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2026-04-08T13:43:01-04:00
3804449 PARK GOVERNMENT RELATIONS, LLC 827572e9-bbdb-45be-8f01-cacd8c9447ee Q1 PARK GOVERNMENT RELATIONS, LLC 401106398 MEDICOM TECHNOLOGIES, INC 2026 first_quarter MED clinical image exchange HOUSE OF REPRESENTATIVES 60000   0 0 2026-04-09T08:40:30-04:00
3804598 CORNERSTONE GOVERNMENT AFFAIRS, INC. d71cea87-37a2-459e-8014-7cc440652c32 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CASE WESTERN RESERVE UNIVERSITY 2026 first_quarter MED Issues related to the FAIR model, federal grants and general higher education issues. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2026-04-09T12:19:09-04:00
3805064 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER ecad0ae0-6d38-49cf-b9c4-0a0aca56322c Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2026 first_quarter MED vaccines, ACIP, 340B, cdc reform, nih reform, pediatric research, NIH budget, FAIR Act, indirect costs, whole genome sequencing, high cost drugs, CMMI Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   28548 0 0 2026-04-10T09:08:04-04:00
3805336 GLAUKOS CORPORATION 55ab303c-980b-4d65-9a4e-b8e5c3c205a2 Q1 GLAUKOS CORPORATION 401108368 GLAUKOS CORPORATION 2026 first_quarter MED Legislation regarding FDA regulation of combination products H.R. 1261/ S. 3302 Mikaela Naylon Give Kids a Chance Act Bill HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2026-04-10T12:06:26-04:00
3805476 UNIVERSITY OF KENTUCKY 82421802-af14-400d-800b-013c6e175009 Q1 UNIVERSITY OF KENTUCKY 400287372 UNIVERSITY OF KENTUCKY 2026 first_quarter MED NIH Funding FY26 HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2026-04-10T14:24:32-04:00
3806039 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 886848fc-f82c-484d-b522-e456d9f00425 Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2026 first_quarter MED Lobbying related to health care issues.   40000   0 0 2026-04-13T09:28:45-04:00
3806096 FEDERAL SOLUTIONS, LLC 8e027f09-c18f-4a24-baad-72ed3812432c Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2026 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-13T10:05:16-04:00
3806439 IPOLICY SOLUTIONS 7b3ac8bd-689f-4b43-b058-dcf2e1ed8003 Q1 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2026 first_quarter MED No bill #: legislation to clarify CLIA Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70500   0 0 2026-04-13T13:49:05-04:00
3806469 IPOLICY SOLUTIONS 92fbb00f-0ece-4e1b-9b61-316cb11d2bc3 Q1 IPOLICY SOLUTIONS 401105127 GUARDANT HEALTH INC. 2026 first_quarter MED FDA-2025-N-4622 Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use with a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order Food & Drug Administration (FDA) 16000   0 0 2026-04-13T13:58:10-04:00
3806832 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 74e6e128-165e-4f5c-8f66-29bf59941753 Q1 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2026 first_quarter MED Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Federal Oversight of Laboratory Tests including Laboratory Developed Testing Services; Physician and Clinical Laboratory Personnel Shortages/workforce issues; Education and Loan Repayment Programs; Appropriations for Federal Agencies; Global Health Initiative; Laboratory Access for Beneficiaries Act; Clinical Laboratory Improvement Amendments; Laboratory oversight; COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform; the RESULTS Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   46000 0 0 2026-04-13T17:26:20-04:00
3806854 PARALYZED VETERANS OF AMERICA 734a1e67-53b4-4594-a2d6-73923a374958 Q1 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2026 first_quarter MED Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   108181 0 0 2026-04-13T18:01:45-04:00
3807081 EFB ADVOCACY, LLC 841fd8f3-3034-44b9-a80e-0a86b95396d5 Q1 EFB ADVOCACY, LLC 401104430 ASSOCIATION OF AMERICAN CANCER INSTITUTES 2026 first_quarter MED Issues related to biomedical research National Institutes of Health appropriations funding Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2026-04-14T09:20:30-04:00
3807099 EFB ADVOCACY, LLC 98810b56-db35-41c2-b7c7-a067d3a8ca13 Q1 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2026 first_quarter MED Funding Issues related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-14T09:25:57-04:00
3807531 CORNERSTONE GOVERNMENT AFFAIRS, INC. c72f75e7-93db-4836-9f6f-820489adc36b Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2026 first_quarter MED Discussions regarding patient access to radiation oncology. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 50000   0 0 2026-04-14T13:00:57-04:00
3807668 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 2101f946-98fb-4776-8ca3-fe38922225f0 Q1 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 OSTEAL THERAPEUTICS, INC. 2026 first_quarter MED General federal government relations HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-14T13:46:17-04:00
3808292 IMPACT MANAGEMENT GROUP 5f7a1bc9-e949-4be4-b32e-73c9a2798741 Q1 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2026 first_quarter MED On behalf of Client support continued and future funding for CARTI in Arkansas HOUSE OF REPRESENTATIVES     0 0 2026-04-14T17:31:14-04:00
3808309 IMPACT MANAGEMENT GROUP 52ce476a-9ccb-40ed-812a-a11d6dc0e6a6 Q1 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2026 first_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-04-14T17:38:40-04:00
3808352 TERRAPOWER, LLC d4dcb2ec-8b4d-4ae1-8cf3-2009ed81ff4d Q1 TERRAPOWER, LLC 401109474 TERRAPOWER, LLC 2026 first_quarter MED Implementation of H.R. 3684, Infrastructure Investment and Jobs Act (IIJA); Implementation of H.R 5376 - Inflation Reduction Act of 2022; Implementation of S. 870 - Fire Grants and Safety Act of 2023; Implementation of H.R.1042 - Prohibiting Russian Uranium Imports Act; Implementation of H.R. 1 - One Big Beautiful Act; FY26 Appropriation; Implementation of H.R. 6938 - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 FY27 Appropriations Commerce, Dept of (DOC),Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2026-04-14T17:47:39-04:00
3808388 CORNERSTONE GOVERNMENT AFFAIRS, INC. ac487c4d-90db-4226-ade3-1ac0a49b1a52 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 LILA SCIENCES, INC. 2026 first_quarter MED Identifying federal funding and legislative opportunities to support scientific superintelligence coupled with autonomous laboratory environments working in life, chemical, and material sciences. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-14T17:57:58-04:00
3808487 BALLARD PARTNERS 7050e842-fed3-404e-9616-3f20f4854900 Q1 BALLARD PARTNERS 401104288 BIOSTAR MEDICAL LLC 2026 first_quarter MED Promoting the advancement of healthcare technology. Health & Human Services, Dept of (HHS) 300000   0 0 2026-04-14T19:41:27-04:00
3808591 WISE CAPITAL STRATEGY, LLC c635e12d-b619-4f86-98a3-d08a584cfa4d Q1 WISE CAPITAL STRATEGY, LLC 401105210 AMITY HOLDINGS LLC DBA PIP DIABETES CARE 2026 first_quarter MED Healthcare and trade issues which may impact efforts to make diabetes care products more accessible. HOUSE OF REPRESENTATIVES,SENATE     0 0 2026-04-14T22:36:09-04:00
3808658 AMERICAN SOCIETY OF ADDICTION MEDICINE b5326e89-bbc1-41d2-8020-6a9817c92b9d Q1 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2026 first_quarter MED Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to r… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   40000 0 0 2026-04-15T08:09:07-04:00
3809059 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 76bd107c-d9f3-4d65-a60c-8876ffe501a3 Q1 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2026 first_quarter MED (MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness Clinical Lab Fee Schedule reform, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act H.R. 5269 / S. 2761 and Medicare coverage of FDA approved breakthrough diagnostics, S.1717 / H.R. 5343 The Ensuring Patient Access to Critical Breakthrough HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2026-04-15T11:32:42-04:00
3809069 CORNERSTONE GOVERNMENT AFFAIRS, INC. e9af38b7-6745-4ab0-b9a8-c1e6a31c87f0 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE UNITED STATES PHARMACOPEIAL CONVENTION 2026 first_quarter MED Issues related to strengthening the resiliency of the U.S. medical supply chain. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2026-04-15T11:39:43-04:00
3809124 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 662af182-57c1-4857-b559-02f670205e83 Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2026 first_quarter MED Medical/Disease Research/Clinical Labs Food & Drug Administration (FDA) 31250   0 0 2026-04-15T11:53:07-04:00
3809227 LIVE OAK STRATEGIES b5673f29-d451-48ca-9bbd-3ca5529138d8 Q1 LIVE OAK STRATEGIES 401105683 KIMERA LABS 2026 first_quarter MED Issues related to lab safety. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2026-04-15T12:16:30-04:00
3809318 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 99a5fb19-f938-477d-9f7d-a4f0b5b5e0c3 Q1 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2026 first_quarter MED * In January 2026, ADLM conducted a grassroots campaign urging it members write to Congress in support of H.R.5269/S.2761, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would create a new, more equitable Medicare clinical laboratory fee schedule. HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2026-04-15T12:56:04-04:00
3809443 CORNERSTONE GOVERNMENT AFFAIRS, INC. 3f5116a0-5b24-44c3-bbea-c24be3836ad0 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MATERIALS AND DEVICES, INC. 2026 first_quarter MED Educated key government stakeholders on AMADs products applicable to the military and supported Defense appropriations requests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2026-04-15T13:37:40-04:00
3809449 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8ce3d769-fad2-441d-a50d-0246f6f60c86 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2026 first_quarter MED HR 7148, FY26 Consolidated Appropriations Act, HR/S unnumbered, FY27 Defense Appropriations Act, Defense Health Research Programs HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-15T13:39:18-04:00
3809480 CORNERSTONE GOVERNMENT AFFAIRS, INC. 80c0ce5a-c8e4-46e2-8b8e-515d3f5b4f8f Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM 2026 first_quarter MED Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness; support Defense appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2026-04-15T13:48:50-04:00
3809504 CORNERSTONE GOVERNMENT AFFAIRS, INC. 1d745de7-d255-403f-860b-309032eebd13 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MEDIVIEW XR, INC. 2026 first_quarter MED Educated government stakeholders on Mediviews technology and capabilities in support of clinical training and graduate medical education; support Defense appropriations. Defense, Dept of (DOD) 40000   0 0 2026-04-15T13:52:23-04:00
3809520 CORNERSTONE GOVERNMENT AFFAIRS, INC. 4094b28b-8545-444e-8fcf-cc693b329828 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 NIRSENSE, LLC (FKA BIONICA LABS) 2026 first_quarter MED Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations requests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-15T13:53:55-04:00
3809533 CORNERSTONE GOVERNMENT AFFAIRS, INC. b5d6013b-3852-4b80-8e9d-925827bb16a7 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 OCTAPHARMA USA, INC. 2026 first_quarter MED Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security. Defense, Dept of (DOD),Executive Office of the President (EOP),SENATE 90000   0 0 2026-04-15T13:57:36-04:00
3809559 CORNERSTONE GOVERNMENT AFFAIRS, INC. 0e50f8fd-66af-4c90-8b0b-bddbb55b77af Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SMITH & NEPHEW 2026 first_quarter MED Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2026-04-15T14:03:59-04:00
3809568 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 42140d67-f257-4ad0-9986-9f5f5b6f14e3 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2026 first_quarter MED H.R. 7148, FY 2026 Consolidated Appropriations Act, Pancreatic Cancer Research Program and NIH research on pancreatic cancer;H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program; H.R./S. Unnumbered FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on pancreatic cancer HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-15T14:04:50-04:00
3809572 CORNERSTONE GOVERNMENT AFFAIRS, INC. 721721c7-af59-4ac6-9f5a-e75d27a70f83 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 TELEFLEX INCORPORATED 2026 first_quarter MED Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. Defense, Dept of (DOD) 20000   0 0 2026-04-15T14:05:39-04:00
3809577 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. baa3c1b2-2cbd-4d50-bcec-42a2ebbb49be Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2026 first_quarter MED H.R. 7148, FY 2026 Consolidated Appropriations Act, Peer Reviewed Medical Research Program designation for peripheral neuropathy and NIH research on peripheral neuropathy; H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for peripheral neuropathy;H.R./S. Unnumbered, FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on peripheral neuropathy HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2026-04-15T14:07:39-04:00
3809580 CORNERSTONE GOVERNMENT AFFAIRS, INC. 004dcebf-806d-4831-9cf3-7a35099f9d82 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE GENEVA FOUNDATION 2026 first_quarter MED Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members; support Defense appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2026-04-15T14:07:48-04:00
3809586 TEAM HALLAHAN LLC cec09168-686d-4bb6-94b2-4b074270a7c2 Q1 TEAM HALLAHAN LLC 401104228 THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION) 2026 first_quarter MED Research and development efforts and FY 26 and FY 27 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2026-04-15T14:09:16-04:00
3809591 CORNERSTONE GOVERNMENT AFFAIRS, INC. b91ca917-12cf-4ccc-bd08-6b8ebc5c57e0 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ 2026 first_quarter MED Educated key government stakeholders on the University's medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2026-04-15T14:10:14-04:00
3809602 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 1f6348b2-2741-4c7d-be8c-271a5b12c507 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2026 first_quarter MED H.R. 7148, FY 2026 Consolidated Appropriations Act,Tuberous Sclerosis Complex Research Program and NIH and CDC funding for tuberous sclerosis complex research and surveillance ;H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; H.R./S. Unnumbered, FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-15T14:15:07-04:00
3809617 CORNERSTONE GOVERNMENT AFFAIRS, INC. e3a4b541-76b6-46f9-b4a3-b9fa77cb04f8 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 WASHINGTON STATE UNIVERSITY 2026 first_quarter MED Educated key government stakeholders on WSUs research and development activities in support of US Service members; support Defense appropriations. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-15T14:16:55-04:00
3809618 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 90c40060-c392-4c37-8ab8-7180d9d19083 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 VHL ALLIANCE 2026 first_quarter MED H.R. 7148, FY 2026 Consolidated Appropriations Act, Peer Reviewed Medical Research Program designation for VHL and NIH research on Von Hippel-Lindau syndrome;H.R./S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for VHL; H.R./S. Unnumbered, FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on Von Hippel-Lindau syndrome HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2026-04-15T14:17:32-04:00
3809647 ADAPTIVE GOVERNMENT RELATIONS cb4bc14c-5589-4e21-b745-d8fd15b80762 Q1 ADAPTIVE GOVERNMENT RELATIONS 401110179 SEATTLE CHILDREN'S 2026 first_quarter MED NIH and pediatric research HOUSE OF REPRESENTATIVES,SENATE 54000   0 0 2026-04-15T14:21:47-04:00
3809681 CORNERSTONE GOVERNMENT AFFAIRS, INC. 48e07218-4e21-4b1f-b655-0a8947eeb450 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 GINKGO BIOWORKS, INC. 2026 first_quarter MED Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2026-04-15T14:31:54-04:00
3809737 THE CORMAC GROUP, LLC f5c0bdb4-1db5-42f1-a337-1b2547b0e759 Q1 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2026 first_quarter MED appropriations, DOD, TBI research, veterans issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-15T14:48:14-04:00
3809740 CORNERSTONE GOVERNMENT AFFAIRS, INC. db301dbb-818d-4234-853b-0a96dc89fedc Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2026 first_quarter MED Health-related issues including reimbursement, research, public-health & clinical care. Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2026-04-15T14:48:47-04:00
3809760 CORNERSTONE GOVERNMENT AFFAIRS, INC. e8ee3331-471f-429e-9dab-0ff9cce9c81d Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2026 first_quarter MED Issues related to Medicare/Medicaid reimbursement and clinical research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2026-04-15T14:50:10-04:00
3810117 CHECKMATE GOVERNMENT RELATIONS d0cbdd33-14e7-455c-8ec7-39497a36ba8a Q1 CHECKMATE GOVERNMENT RELATIONS 401109039 SANOFI US SERVICES INC. 2026 first_quarter MED There is no current bill filed. Working on Issues related to health care and drug pricing. Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),U.S. Trade Representative (USTR),White House Office 90000   0 0 2026-04-15T15:58:05-04:00
3810266 CHECKMATE GOVERNMENT RELATIONS 948fec89-9493-4568-b44a-44bc490a296a 1T CHECKMATE GOVERNMENT RELATIONS 401109039 VANTIVE HEALTH LLC 2026 first_quarter MED There is no current bill filed. Focused engagement with HHS for medical technologies regarding organ support devices. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),White House Office 110000   0 1 2026-04-15T16:12:38-04:00
3810336 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 35febaeb-7d19-462b-8697-66718f183a5d Q1 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2026 first_quarter MED No bill number - Urge NIH to continue funding for therapy research Natl Institutes of Health (NIH)   189000 0 0 2026-04-15T16:18:36-04:00
3810982 BALLARD PARTNERS 243d6b1e-43e4-4ea4-9c42-9afb0a1319ca Q1 BALLARD PARTNERS 401104288 INSIGHTEC, INC. 2026 first_quarter MED Guidance on legislation and regulations regarding medical devices; advocacy regarding the use of medical devices at the VA. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 90000   0 0 2026-04-15T21:21:17-04:00
3811037 ACORN CONSULTING c7c44c6d-f572-48ca-bf5a-d31dddd4cf59 Q1 ACORN CONSULTING 401107972 THORAGENIX INNOVATIONS, INC. 2026 first_quarter MED Advancing study and approval for medical devices HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2026-04-15T22:14:54-04:00

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 113.072ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API